Inclusion Criteria:  Men with PCa (primary or recurrent disease) Men who received a 68Ga-PSMA-11 positron emission tomography (PET)/computed tomography (CT) for staging or restaging Men with evidence of lymph nodes (LNs)-positive disease on 68Ga-PSMA-11 PET/CT Men who are scheduled for pelvic LN dissection (PLND) Men who can provide oral and written informed consent Men who can comply with study procedures  Exclusion Criteria:  Patients who started any PCa treatment between study enrollment and surgery Technically inaccessible nodal location